Literature > Citations/Published Articles > IL-23


Stenderup K et al. “AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model.” Protein Engineering Design and Selection. 28(10):467-80 (2015).
PMID: 26271488

Endo Y et al. “Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1.” Cell Reports 12, no. 6 (2015): 1042-55.
PMID: 26235623

Raymond Y et al. “The Human IL-23 Receptor rs11209026 A Allele Promotes the Expression of a Soluble IL-23R–Encoding mRNA Species.” The Journal of Immunology 194, no. 3 (2015): 1062–68.
PMID: 25552541

Tanimoto A et al. “Pharmacological Properties of JTE-052: A Novel Potent JAK Inhibitor That Suppresses Various Inflammatory Responses in Vitro and in Vivo.” Inflammation Research 64, no. 1 (2015): 41–51.
PMID: 25387665

Tominaga A et al. “Autonomous Cure of Damaged Human Intestinal Epithelial Cells by TLR2 and TLR4-Dependent Production of IL-22 in Response to Spirulina Polysaccharides.” International Immunopharmacology 17, no. 4 (2013): 1009–19.
PMID: 24126111

Suzuki H et al. “IL-23 Directly Enhances the Proliferative and Invasive Activities of Colorectal Carcinoma.” Oncology Letters 4, no. 2 (2012): 199–204.
PMID: 22844353

Magalhaes I et al. “High Content Cellular Immune Profiling Reveals Differences between Rhesus Monkeys and Men.” Immunology 131, no. 1 (2010): 128–40.
PMID: 20465573

Human Cell Expressed

Animal Component-Free, Xeno-Free Production